Delivery Order SPE2DB22D2007-SPE2DB24FH7ET
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,486.10, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Xulane 150-35 mcg/day patch. The $8,922.64 firm fixed-price contract has a completion date of May 25, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of XULANE 150-35 MCG/DAY PATCH 3S. The award, valued at $1,982.51, is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of October 13, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This contract...
- This federal contract award, valued at $2,854.52, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of December 6, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,784.02 firm-fixed-price delivery order is for the provision of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the Department of...
- This contract award, valued at $1,699.72, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes...
- This federal contract award, valued at $6,319.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award is a delivery order valued at $1,187.55 for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2024 and is a firm fixed price delivery order. Amerisourcebergen Drug Corp, through its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,358.26 contract is a firm fixed-price delivery order for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of April 28, 2023. The contract was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,234.59, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH7ETDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,954.31, is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is November 17, 2023. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/16/23 |